<DOC>
	<DOCNO>NCT00786305</DOCNO>
	<brief_summary>Pseudomonas aeruginosa one major causative microorganism ventilator-associated pneumonia often resistant antibiotic . In experimental model , nebulization antibiotic delivers high lung tissue concentration antibiotic infect lung increase lung bacterial killing . The aim study assess efficiency nebulized ceftazidime amikacin treatment pneumonia cause Pseudomonas aeruginosa ventilate patient .</brief_summary>
	<brief_title>Nebulized Ceftazidime Amikacin Ventilator Associated Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<criteria>Male female &gt; 18 year old , ventilator associate pneumonia cause pseudomonas aeruginosa Written inform consent provide relative Pseudomonas aeruginosa resistant ceftazidime amikacin Pseudomonas aeruginosa pneumonia associate infection require intravenous treatment Severe septic shock severe hypoxemia Allergy ceftazidime amikacin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Nebulization</keyword>
	<keyword>ceftazidime</keyword>
	<keyword>amikacin</keyword>
	<keyword>pneumonia</keyword>
	<keyword>Pseudomonas aeruginosa</keyword>
	<keyword>mechanical ventilation</keyword>
	<keyword>Ventilator-associated pneumonia</keyword>
	<keyword>treatment</keyword>
</DOC>